138 related articles for article (PubMed ID: 38441194)
21. Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Payne K; Pugh M; Brooks J; Batis N; Taylor G; Nankivell P; Mehanna H
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153130
[TBL] [Abstract][Full Text] [Related]
22. Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma.
Mendelsohn AH; Lai CK; Shintaku IP; Fishbein MC; Brugman K; Elashoff DA; Abemayor E; Dubinett SM; St John MA
Am J Otolaryngol; 2012; 33(1):6-13. PubMed ID: 21439681
[TBL] [Abstract][Full Text] [Related]
23. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A
Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757
[TBL] [Abstract][Full Text] [Related]
24. Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.
Campbell NP; Hensing TA; Bhayani MK; Shaikh AY; Brockstein BE
Expert Rev Anticancer Ther; 2016 Aug; 16(8):847-58. PubMed ID: 27400139
[TBL] [Abstract][Full Text] [Related]
25. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
26. Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck.
Lee JW; Soung YH; Kim SY; Nam HK; Park WS; Nam SW; Kim MS; Sun DI; Lee YS; Jang JJ; Lee JY; Yoo NJ; Lee SH
Clin Cancer Res; 2005 Apr; 11(8):2879-82. PubMed ID: 15837736
[TBL] [Abstract][Full Text] [Related]
27. Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: initial results.
Jatana KR; Balasubramanian P; Lang JC; Yang L; Jatana CA; White E; Agrawal A; Ozer E; Schuller DE; Teknos TN; Chalmers JJ
Arch Otolaryngol Head Neck Surg; 2010 Dec; 136(12):1274-9. PubMed ID: 21173379
[TBL] [Abstract][Full Text] [Related]
28. The role of p16 expression as a predictive marker in HPV-positive oral SCCHN--a retrospective single-center study.
Geißler C; Tahtali A; Diensthuber M; Gassner D; Stöver T; Wagenblast J
Anticancer Res; 2013 Mar; 33(3):913-6. PubMed ID: 23482761
[TBL] [Abstract][Full Text] [Related]
29. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
[TBL] [Abstract][Full Text] [Related]
30. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
31. Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.
Wheeler S; Siwak DR; Chai R; LaValle C; Seethala RR; Wang L; Cieply K; Sherer C; Joy C; Mills GB; Argiris A; Siegfried JM; Grandis JR; Egloff AM
Clin Cancer Res; 2012 Apr; 18(8):2278-89. PubMed ID: 22351687
[TBL] [Abstract][Full Text] [Related]
32. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG; Saba NF
Cancer; 2015 Oct; 121(20):3600-11. PubMed ID: 26195293
[TBL] [Abstract][Full Text] [Related]
33. Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma.
Blackwell JL; Miller CR; Douglas JT; Li H; Reynolds PN; Carroll WR; Peters GE; Strong TV; Curiel DT
Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):856-63. PubMed ID: 10448731
[TBL] [Abstract][Full Text] [Related]
34. Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.
Van Allen EM; Lui VW; Egloff AM; Goetz EM; Li H; Johnson JT; Duvvuri U; Bauman JE; Stransky N; Zeng Y; Gilbert BR; Pendleton KP; Wang L; Chiosea S; Sougnez C; Wagle N; Zhang F; Du Y; Close D; Johnston PA; McKenna A; Carter SL; Golub TR; Getz G; Mills GB; Garraway LA; Grandis JR
JAMA Oncol; 2015 May; 1(2):238-44. PubMed ID: 26181029
[TBL] [Abstract][Full Text] [Related]
35. Molecular targeted therapies in the management of head and neck squamous cell carcinoma: recent developments and perspectives.
Bozec A; Peyrade F; Milano G
Anticancer Agents Med Chem; 2013 Mar; 13(3):389-402. PubMed ID: 23092267
[TBL] [Abstract][Full Text] [Related]
36. Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs.
Li S; Hanna E; Breau R; Ratanatharathorn V; Xia X; Suen J
Br J Cancer; 2004 Mar; 90(5):1093-9. PubMed ID: 14997212
[TBL] [Abstract][Full Text] [Related]
37. Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer.
Argiris A; Duffy AG; Kummar S; Simone NL; Arai Y; Kim SW; Rudy SF; Kannabiran VR; Yang X; Jang M; Chen Z; Suksta N; Cooley-Zgela T; Ramanand SG; Ahsan A; Nyati MK; Wright JJ; Van Waes C
Clin Cancer Res; 2011 Sep; 17(17):5755-64. PubMed ID: 21750205
[TBL] [Abstract][Full Text] [Related]
38. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
[TBL] [Abstract][Full Text] [Related]
39. Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.
Chen ZW; Weinreb I; Kamel-Reid S; Perez-Ordoñez B
Head Neck Pathol; 2012 Dec; 6(4):422-9. PubMed ID: 22801997
[TBL] [Abstract][Full Text] [Related]
40. Identification of an 8 HPV-related RNA signature as a novel prognostic biomarker for squamous cell carcinoma of the head and neck.
Mei Z; Zhengdong L; Shupeng L; Xin Z; Lei W; Wang C
Medicine (Baltimore); 2024 Feb; 103(6):e36448. PubMed ID: 38335428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
